. Benefit-risk considerations in the treatment of dementia with Lewy bodies. Drug Saf. 2002;25(7):511-23. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.